Nebula Research & Development Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$1.7M |
| 2 |
SLB Ltd
SLB
|
+$1.68M |
| 3 |
DAY
Dayforce
DAY
|
+$1.59M |
| 4 |
Idacorp
IDA
|
+$1.58M |
| 5 |
Visa
V
|
+$1.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$968K |
| 2 |
Archer Daniels Midland
ADM
|
+$967K |
| 3 |
HCA Healthcare
HCA
|
+$966K |
| 4 |
Abbott
ABT
|
+$966K |
| 5 |
S&P Global
SPGI
|
+$965K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.79% |
| 2 | Healthcare | 14.71% |
| 3 | Industrials | 14.47% |
| 4 | Consumer Discretionary | 11.29% |
| 5 | Financials | 9.21% |
Similar funds
Nebula Research & Development's Q4 2023 Portfolio in Review
As of Q4 2023, Nebula Research & Development held 913 positions worth $332M, up 75% from $190M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.
Nebula Research & Development deployed $119M of net new capital in Q4 2023, opening 440 new positions and adding to 113 existing holdings. Its largest new stake was Humana: 3,439 shares worth $1.57M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Hanesbrands, an estimated $775K trimmed.
- Nebula Research & Development's largest Q4 2023 buy was Humana: 3,439 shares worth $1.57M.
- Nebula Research & Development added most to AppFolio in Q4 2023, an estimated $1.43M increase.
- Nebula Research & Development's biggest Q4 2023 reduction was Hanesbrands, cutting an estimated $775K.
- Nebula Research & Development fully exited Intuit in Q4 2023, selling an estimated $968K.
- Nebula Research & Development's ten largest holdings make up 4.8% of its $332M portfolio in Q4 2023.
- Nebula Research & Development opened 440 new positions and closed 294 in Q4 2023.
- Nebula Research & Development's portfolio value rose 75% quarter-over-quarter to $332M.
Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.